← All organizations

Peptimmune

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Jul 1, 2003

Acquired by Genzyme → Sanofi-Aventis on Jan 1, 1999

Timeline

1990s

Jan 1, 1997
Peptimmune— Founded
Jan 1, 1999
Genzyme— Acquired By

2010s

Jan 1, 2011
Sanofi-Aventis— Now

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

pi-0824

Indications

Studied for

Pemphigus

Recent trials (1)

NCT00063752Lead sponsorPhase 1Jul 1, 2003

Details

Founded: Cambridge, MA, US Jan 1, 1997
Last known activity: Jul 1, 2003